Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Epogen

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Epogen was produced by Amgen.

Omontys terminal as Takeda switches off support

Omontys terminal as Takeda switches off support by Epogen (epoetin alfa) and long-acting follow-up Aranesp (darbepoetin alfa).

Amgen buys total filgrastim rights from Roche

Amgen buys total filgrastim rights from Roche alfa) fell 10 per cent to $449m and short-acting Epogen (epoetin alfa) was flat at $491m.

Amgen and Onyx agree $10.4bn takeover deal

Amgen and Onyx agree $10.4bn takeover deal Amgen is no exception, with biosimilars already eating into the market share of its first-generation products such as Epogen (epoetin alfa) and Neupogen (filgrastim), as well as longer-acting versions

Onyx rejects $10bn takeover bid from Amgen

Onyx rejects $10bn takeover bid from Amgen back of declining sales for its anaemia products Epogen (epoetin alfa) and Aranesp (darbepoetin alfa) and white cell stimulators Neupogen (filgrastim) and Neulasta (pegfilgrastim).

FDA clears Amgen's Xgeva for rare bone condition

FDA clears Amgen's Xgeva for rare bone condition from declining sales of its red blood cell stimulators Epogen (epoetin alfa) and Aranesp (darbepoetin alfa).

[ Previous 5 results ] 1 2 3 4 5 6 7 8 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics